Top scientists gather for meeting on groundbreaking advances and pioneering innovations in cell-based therapeutic approaches to cardiovascular diseases. WHAT: The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) is a three-day comprehensive program dedicated to the evolving field of cell-based therapies for treating cardiovascular diseases. Continue reading ...
Children born to mothers with pregnancy-related diabetes run twice the risk of language development problems, according to a research team directed by Professor Ginette Dionne of Université Laval's School of Psychology. Details of this discovery are published in the most recent issue of the scientific journal Pediatrics. Continue reading ...
Brandeis University has announced a multi-year $1 million sponsored research agreement with Smart Balance Inc. through its wholly owned subsidiary, the maker of Smart Balance® buttery spread and other low-fat and fat-free foods that help lower cholesterol through a patented blend of natural vegetable oils. In addition, Brandeis and Smart Balance have entered into a collaboration and license to develop a second-generation heart-healthy fat for Smart Balance. Continue reading ...
The recognition of health as a central economic and societal driving force requires new approaches to how health policy is conducted. Policy innovations - in particular mechanisms that recognize the critical role of patients and consumers and that involve a wide range of stakeholders - will be the defining factor for health sustainability in the 21st century. Continue reading ...
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today updated shareholders at their Annual General Meeting in Adelaide, Australia on the Phase I/IIa clinical trial of DiabeCell®, LCT's lead product candidate for the treatment of insulin dependent (Type 1) diabetes. A total of six patients have been implanted with DiabeCell® to date; five patients received the lowest dose of 5,000 islet equivalents (IEQ/kg), and one patient was dosed with 10,000 IEQ/kg. Continue reading ...
Joslin Diabetes Center today announced that C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research. "Joslin Diabetes Center is delighted that one of our world-renowned researchers has been named the inaugural winner of such a prestigious award," said Ranch C. Continue reading ...
Sunday, November 9, 2008
Holistic Thrush Treatment Can Provide Freedom From Candida For Good!
Did you know that around three quarters of women and some fifty percent of men need thrush treatment at some time in their lives? Did you also realize that of these only about five in one hundred effectively cure their yeast infection permanently using conventional. modern medicines? If you are one of the 75% who suffer from yeast infection symptoms and are seeking a natural yeast infection remedy that could help you conquer the illness for good then here is some good news.
Subscribe to:
Posts (Atom)
